Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Posted on by ScienceFather

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. πŸ§‘β€πŸ”¬πŸ‘©β€πŸ«πŸ”¬

Publication Profile

Google Scholar

Work Experience πŸŒπŸ’Ό

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. πŸ“šπŸŒπŸ‘©β€πŸ”¬

 

Qualifications πŸŽ“πŸŒŸ

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. πŸ§ͺπŸ“˜πŸ‘©β€πŸ”¬

 

Additional Experience πŸŒπŸ”¬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. πŸ“šπŸ’‘πŸ“ˆ

 

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry πŸ’Š. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials πŸ—οΈ, photocatalysis βš›οΈ, and nanomaterials πŸ§ͺ with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design πŸ’», enzyme inhibition πŸ§ͺ, and therapeutic applications for diseases like malaria and cancer.

 

Publication Top Notes Β 

  • Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) πŸ”‹
  • Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) πŸ’Š
  • Inhibition of the Ξ²-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
  • Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) πŸ’‘
  • Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) πŸ”¬
  • Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
  • Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) πŸ’§
  • The first activation studies of the Ξ·-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
  • New quinoxalinone inhibitors targeting secreted phospholipase A2 and Ξ±-glucosidase (28 citations, 2017) πŸ§ͺ
  • Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

 

Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Dr. Pavitra Dewda, GSK – GlaxoSmithKline, Belgium

Dr. Pavitra Dewda is a seasoned Global Medical Director with over a decade of experience in the pharmaceutical and biotechnology industries, specializing in medical strategy, clinical development, and vaccine lifecycle management. Currently at GlaxoSmithKline, she leads global medical strategies for vaccines, focusing on hepatitis, pertussis, and pneumococcal vaccines. Previously, she held leadership roles at Merck KGaA and Sanofi Pasteur, driving initiatives in medical affairs and scientific engagement. Dr. Dewda has been recognized with multiple global awards for her contributions to vaccine education, regulatory affairs, and medical strategy. πŸŒπŸ’‰πŸ’ŠπŸ“ˆπŸ‘©β€πŸ”¬

 

Publication Profile

Scopus

Education & Professional Development

 

Dr. Pavitra Dewda holds an MD from Padmashree Dr. D.Y. Patil University, Pune (2011), and an MBBS from Maharashtra University of Medical Science (2005). Her strong educational foundation in medicine has enabled her to excel in the global pharmaceutical industry. With a passion for medical strategy and vaccine development, Dr. Dewda continues to enhance her expertise through ongoing professional development in clinical affairs, regulatory management, and public health. Her education forms the bedrock for her impactful career in global medical leadership. πŸŽ“πŸ’‰πŸ“šπŸ‘©β€βš•οΈ

Executive Career Synopsis & Highlights

Dr. Pavitra Dewda is a seasoned global medical leader, currently serving as Global Medical Director at GlaxoSmithKline (GSK) since December 2022. She leads global medical lifecycle accountability for key vaccine portfolios, including hepatitis and pertussis, and drives strategic partnerships, advocacy, and medical strategy. Previously, she was General Manager Medical at GSK India, where she led medical operations, secured regulatory approvals, and executed successful vaccine launches. Dr. Dewda has also held leadership roles at Sanofi and Merck KGaA, excelling in medical affairs, strategic initiatives, and digital transformation, receiving multiple awards for her innovative contributions. πŸ’‰πŸŒπŸŽ“

 

Research Focus

Dr. Pavitra Dewda’s research focuses primarily on vaccinology πŸ¦ πŸ’‰, infectious diseases 🦠, medical affairs 🩺, and fertility medicine πŸ‘Ά. She has contributed to studies on hepatitis A and B vaccination for at-risk adults in Europe, emphasizing healthcare professionals’ knowledge, attitudes, and practices. Dr. Dewda also co-authored research on vaccinating healthcare providers in India, showcasing the importance of immunization in healthcare settings. Additionally, she has explored fertility treatments 🌱, particularly in in vitro fertilization (IVF) outcomes, demonstrating her expertise in both public health and reproductive health. Her work blends clinical research and medical strategy.

 

Publication Top Notes

  • “Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults” – Vaccines, 2023, 11(11), 1645 πŸ¦ πŸ’‰ | Cited by: 1
  • “A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review” – Infectious Diseases and Therapy, 2022, 11(1), 81–99 πŸ©ΊπŸ’‰ | Cited by: 5
  • “Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles” – Frontiers in Endocrinology, 2018, 9(APR), 201 πŸ‘Άβš—οΈ | Cited by: 23

 

 

Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Posted on by ScienceFather

Dr. Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie, David Umahi Federal University of Health Sciences, Nigeria

Dr. Chigozie Victor Uchenna is a Lecturer I at David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria, where he also serves as the acting head of the Department of Pharmaceutical Microbiology and Biotechnology. He completed his Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, where his research focused on the identification and bioactivities of secondary metabolites from fungi. Dr. Chigozie has extensive teaching and research experience, including in pharmaceutical microbiology, biotechnology, and the study of natural products. His key research areas include bioactive compounds, antimicrobial agents, and cancer therapeutics.

Publication Profile

Orcid

Google Scholar

Educational Background πŸŽ“

Dr. Victor Chigozie holds a Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, Nigeria, where his research focused on the identification and bioactivities of secondary metabolites from Aspergillus species and Daldinia eschscholtzii found in Mangifera indica and Musa paradisiaca leaves. He graduated with first-class honors (4.69/5.0) in 2021. Dr. Chigozie also completed an M.Sc. in Pharmaceutical Microbiology and Biotechnology at the same university, with research on the quality assessment of tetanus toxoid brands in southeastern Nigeria’s markets, publishing his findings. He holds a B.Sc. in Applied Microbiology with second-class honors (4.12/5.0) and a Senior School Certificate with Upper Credit. πŸŽ“πŸ“šπŸ”¬

 

Professional Experience πŸ§‘β€πŸ”¬

Dr. Victor Chigozie has held several key positions in academic and government institutions, contributing significantly to research and development. As a Lecturer I and Acting Head of Pharmaceutical Microbiology and Biotechnology at David Umahi Federal University of Health Sciences, Ebonyi State, he has been instrumental in coordinating classes, practicals, and research, especially in natural products and pharmaceutical biotechnology. He set up a BSL-2 lab and contributed to the development of practical manuals.

Teaching Experience πŸ“šπŸ‘¨β€πŸ«

Dr. Victor Chigozie has a rich teaching history, contributing extensively to pharmaceutical sciences. At David Umahi Federal University of Health Sciences, Uburu, he has taught several courses, including Introductory Pharmaceutical Microbiology (PHM 201) and Molecular Biology (PHM 202) since 2022, alongside practicals in both subjects. His expertise extends to Pharmaceutical Microbiology I (PHM 301), Aseptic Processes and Sterilization Technology (PHM 302), and Bioinformatics, Pharmacogenetics, and Pharmacogenomics (PHM 382), all of which he began teaching in 2024. Additionally, he teaches courses on integrated pharmacotherapy and sterile product technology.

 

Awards and Recognitions πŸ†πŸŽ–οΈ

Dr. Victor Chigozie has received numerous prestigious awards for his contributions to pharmaceutical microbiology and biotechnology. Notably, he was named Top Cite Author by Wiley Publishers for 2022-2023. He also received a Travel Grant Award from the Wuhan Institute of Virology (2023) and the National Foundation for Infectious Diseases (2012). Dr. Chigozie was honored with the Ph.D. Award for being the top of his class at Nnamdi Azikiwe University (2021). Additionally, he won the CBN-NYSC-NDE Venture Prize Competition during his NYSC service for the Best Business Proposal (2010). πŸ…πŸ“š

 

Research Focus

 

Dr. Victor Chigozie’s research spans a wide array of topics in pharmaceutical microbiology, biotechnology, and public health. His work includes antibiotic resistance, exploring emerging strategies to tackle global health challenges. He has contributed significantly to bioactive compounds and endophytic fungi, studying their potential in antimicrobial, anti-inflammatory, and analgesic activities. His research also delves into pharmacovigilance, self-medication practices, and the role of community pharmacies in healthcare systems. Additionally, Dr. Chigozie investigates biosecurity, biosafety, and differentiated care models for diseases like HIV/AIDS. His focus on indigenous knowledge in managing emerging infectious diseases in Africa highlights his commitment to improving health through both modern science and traditional insights. πŸŒ±πŸ’Š

 

Publication Top Notes

  • Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace – D Chinemerem Nwobodo, MC Ugwu, C Oliseloke Anie, MTS Al‐Ouqaili, … (Cited by: 405, Year: 2022) 🦠
  • Evaluation of the analgesic, anti-inflammatory and antimicrobial activities of leaf extracts of Breynia nivosa – FA Onyegbule, IO Ilouno, PM Eze, CC Abba, VU Chigozie (Cited by: 19, Year: 2014) 🌿
  • Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca – V Chigozie, M Okezie, E Ajaegbu, F Okoye, C Esimone (Cited by: 13, Year: 2020) 🍌
  • Bioactivities and HPLC analysis of secondary metabolites of a morphologically identified endophytic Aspergillus fungus isolated from Mangifera indica – VU Chigozie, MU Okezie, EE Ajaegbu, FB Okoye, CO Esimone (Cited by: 11, Year: 2022) πŸ₯­
  • Larvicidal and synergistic potentials of some plant extracts against Aedes aegypti – GT Onah, EE Ajaegbu, CC Ezeagha, VU Chigozie, AM Bello, P Chinelo (Cited by: 3, Year: 2022) 🦟
  • Practice, Risk Perception, and Correlates of Self-Medication Among Pregnant Women in Awka – OOB Anthony Maduka, Daniel U. Eze, Victor U. Chigozie (Cited by: 2, Year: 2024) πŸ’Š
  • Community Pharmacies, Extent of Services, and Preparedness for Primary Health Care Policy Implementation in Nigeria from 1980 to 2022: A Narrative Review – M Maureen, DU Eze, OC Clementina, N Monica, VU Chigozie, O Brian O (Cited by: 1, Year: 2024) πŸ₯
  • Quality Assessment of Some Brands of Tetanus Toxoids Marketed in Open Markets in South-Eastern Nigeria – VU Chigozie, PM Eze, CR Chukwunwejim, CC Abba, CS Nworu, … (Cited by: 1, Year: 2014) πŸ’‰
  • Identification of Some Bioactive Compounds from Camellia sinensis as Possible Inhibitors of human epidermal growth factor receptor 2 (HER2) – LN Ebenyi, CBG Egwuom, EM Halilu, AP Obialor, TO Johnson, … (Year: 2024) 🍡
  • Antioxidative, anti-androgenic, and inhibitory activities of ethanolic extract of Annona muricata leaf on sex hormones-induced benign prostate hyperplasia through in vivo and … – DDCBA Lilian N. Ebenyi, Victor U. Chigozie (Year: 2024) πŸƒ

Suresh V Chennupati | Medicinal Chemistry | Best Faculty Award

Posted on by ScienceFather

Prof Dr. Suresh V Chennupati | Medicinal Chemistry | Best Faculty Award

Prof Dr. Suresh V Chennupati, Nalanda College of Pharmacy, India

Prof. Dr. Suresh V. Chennupati is an esteemed educator and researcher in pharmaceutical sciences, holding a B. Pharmacy from Gulbarga University and an M. Pharmacy in Pharmaceutical Chemistry from Rajiv Gandhi University. He earned his PhD from Acharya Nagarjuna University and an honorary DSc from Mount Elbert University, USA. Currently, he serves as the Head of the Department of Pharmaceutical Analysis at Nalanda College of Pharmacy, Telangana. With over 50 publications and multiple awards, including the Best Pharmacy Teacher Award (2022) and National Youth Icon Award (2023), Dr. Chennupati is recognized for his significant contributions to pharmaceutical education and research. πŸ“šπŸ†πŸ’Š

 

Publication profile

Google Scholar

Academic Background

Prof. Dr. Suresh V Chennupati holds a solid academic foundation in pharmaceutical sciences, beginning with his Bachelor of Pharmacy from Gulbarga University, Karnataka. He furthered his education with a Master’s in Pharmaceutical Chemistry from Rajiv Gandhi University of Health Sciences, Bangalore, and a PhD from Acharya Nagarjuna University, Guntur. His honorary Doctor of Science (DSc) in Pharmaceutical Sciences from Mount Elbert University, USA, underscores his expertise and commitment to the field.

Professional Experience

Currently serving as the Professor & Head of the Department of Pharmaceutical Analysis at Nalanda College of Pharmacy, Nalgonda, Telangana State, Dr. Chennupati has held numerous prestigious positions throughout his career. His previous roles include Principal at Green Royal Academy of Pharmaceutical Education and Sciences and Mother Teresa Pharmacy College, and he has also served as Associate Professor and Assistant Professor at various esteemed institutions both in India and abroad.

Awards and Recognition

Dr. Chennupati’s contributions to pharmaceutical education have been recognized with several prestigious awards, including the Bharat Siksha Ratan Award in 2013 and the APP Young Performer Award in 2014. His dedication to education was further acknowledged when he received the India International Achievers Award for Educational Excellence and multiple awards for his excellence in teaching, such as the BEST PHARMACY TEACHER AWARD-2022 from the Telangana State Pharmacy Council.

Conclusion

Prof. Dr. Suresh V Chennupati exemplifies the qualities of an outstanding faculty member through his extensive educational background, significant contributions to pharmaceutical education and research, and numerous accolades. His dedication to the field and continuous pursuit of excellence makes him a suitable candidate for the Research for Best Faculty Award.

 

Publication Top Notes Β 

  • Natural bioactive thiazole-based peptides from marine resources: structural and pharmacological aspects – Cited by: 60, Year: 2020 πŸ“–πŸŒŠ
  • First total synthesis and biological screening of a proline-rich cyclopeptide from a Caribbean marine sponge – Cited by: 43, Year: 2016 πŸ§ͺ🐚
  • Natural bridged bicyclic peptide macrobiomolecules from celosia argentea and amanita phalloides – Cited by: 26, Year: 2022 πŸŒΏπŸ„
  • Synthesis and bioactivity of a cyclopolypeptide from Caribbean marine sponge – Cited by: 25, Year: 2020 🧬🐠
  • Total synthesis and pharmacological investigation of cordyheptapeptide A – Cited by: 21, Year: 2017 πŸ”¬πŸ’Š
  • First total synthesis and pharmacological potential of a plant-based hexacyclopeptide – Cited by: 10, Year: 2019 πŸŒ±βš—οΈ
  • Evaluation of antibiotics use and prescribing error among hospitalized pediatric patients in Nekemte Referral Hospital, Ethiopia – Cited by: 4, Year: 2017 πŸ₯πŸ‘Ά
  • Towards the Synthesis of a Heterocyclic Analogue of Natural Cyclooligopeptide with Improved Bio-properties – Cited by: 1, Year: 2022 πŸ”„πŸ§ͺ
  • Assessment of Knowledge, Attitude and Practices of Condom Use among People Living With HIV/AIDS in Nekemte Referral Hospital, West Ethiopia – Cited by: 1, Year: 2017 πŸ§‘β€πŸ€β€πŸ§‘πŸ’¬
  • UV-Visible spectrophotometric method development and validation of assay for Etofylline tablet formulation – Cited by: 1, Year: 2014 πŸ”¬πŸ’Š

 

 

Eman Helmy Ahmed Abdelmonaim | Pharmaceutical Sector Award | Women Researcher Award

Posted on by ScienceFather

Dr. Eman Helmy Ahmed Abdelmonaim | Pharmaceutical Sector Award | Women Researcher Award

Dr. Eman Helmy Ahmed Abdelmonaim, National Research Centre NRC, Egypt

Eman Helmy Ahmed Abdelmonaim is an accomplished Egyptian researcher specializing in polymer science and nanotechnology. With a Ph.D. in Chemistry, she has conducted extensive research and received recognition for her work, including prestigious fellowships and awards. Her expertise spans various fields, from organic chemistry to spectroscopic techniques. Eman has contributed significantly to scientific conferences and publications, showcasing her innovative contributions to the field. With a passion for learning and a resilient attitude, she continues to excel in her endeavors, aiming to make impactful contributions to the scientific community. πŸ§ͺπŸ”¬

 

Publication Profile

Google Scholar

Education and QualificationΒ 

Eman Helmy pursued her academic journey with dedication, starting from Al-Azhar Language School for her high school education in Nasr City, Egypt. She then obtained her Bachelor of Science degree in Special Chemistry from Al Azhar University, graduating with distinction in 2005. Her passion for organic chemistry led her to pursue further studies, culminating in a Master’s degree in Organic Chemistry from Cairo University in 2014. Her research focus on the preparation and characterization of polymeric nanocomposites earned her acclaim, with her thesis being examined by Prof. Dr. Patricia Heiden from Michigan Technological University, USA. In 2019, she successfully completed her Ph.D. in Chemistry, delving into the preparation of polymeric materials embedded in nano-structured oxides through joint supervision from Ain Shams University, Egypt, and Siegen University, Germany. πŸ“šπŸŽ“

 

Research Focus

Eman Helmy Ahmed’s research focus revolves around the synthesis and characterization of advanced nanocomposites for various applications, particularly in dielectric materials and optical waveguide technologies. Her work encompasses the preparation and evaluation of hyperbranched polymers embedded with nanoparticles like montmorillonite clay and phosphosilicate, aiming at enhancing their dielectric and optical properties. Through her investigations, she explores the potential of these materials in fields such as electrical applications, planar optical waveguides, and friction coefficient modulation. Eman’s dedication to advancing nanotechnology contributes significantly to the development of innovative solutions for industrial and scientific challenges. πŸ”¬βœ¨

 

Publication Top NotesΒ 

  1. Preparation and evaluation of hyperbranched p-chloromethyl styrene polymers/ montmorillonite clay nanocomposites as dielectric materials πŸ“ Cited by: 17, Year: 2015
  2. Phosphosilicate–polyamidoamine hyperbranched polymer–Er3+Β nanocomposite toward planar optical waveguide applications πŸ“ Cited by: 13, Year: 2019
  3. Nanocomposites dendritic polyamidoamine-based chitosan hyperbranched polymer embedded in silica–phosphate for waveguide applications πŸ“ Cited by: 10, Year: 2021
  4. Influence of dispersing lithium grease by hybrid nano titanium and silicon oxides on friction coefficient πŸ“ Cited by: 10, Year: 2018
  5. Thermal Effect of Er³⁺ Ions Embedded in Smart Nano-Composite Oxide Material Prepared by Sol-Gel Technique πŸ“ Cited by: 10, Year: 2017
  6. Synthesis and cytotoxic activities of selenium nanoparticles incorporated nano-chitosan πŸ“ Cited by: 7, Year: 2024
  7. Influence of adding contaminants particles to lithium grease on the frictional coefficient πŸ“ Cited by: 6, Year: 2017
  8. Morphological and spectroscopical characterization of hyperbranched polyamidoamine–zwitterionic chitosan‑encapsulated 5‑FU anticancer drug πŸ“ Cited by: 5, Year: 2020
  9. Physical Properties of Tb3+ and Ho3+ Ions Embedded in Nanocomposites Phospho-SilicateπŸ“ Cited by: 5, Year: 2020
  10. Dielectric behavior of some vinyl polymers/montmorillonite nanocomposites on the way to apply them as semiconducting materials πŸ“ Cited by: 5, Year: 2013